1. AHRO : Austin Health Research Online

Hui K Gan

View Statistics Email Alert RSS Feed
 Claim profile

Profile

Loading... 2 0 20 0 false
Credit Name
Hui K Gan
Full Name
Gan, Hui K
 
Variants
Gan, Hui Kong
 
Department
 
ORCID
Loading... 3 0 20 0 false

Publications

Results 101-120 of 121 (Search time: 0.007 seconds).

Publication YearTitleAuthor(s)
101Dec-2015First in human nanotechnology doxorubicin delivery system to target epidermal growth factor receptors in recurrent glioblastoma.Whittle, James R; Lickliter, Jason D; Gan, Hui K ; Scott, Andrew M ; Simes, John; Solomon, Benjamin J; MacDiarmid, Jennifer A; Brahmbhatt, Himanshu; Rosenthal, Mark A
10223-Feb-2015MitoPhAST, a new automated mitogenomic phylogeny tool in the post-genomic era with a case study of 89 decapod mitogenomes including eight new freshwater crayfish mitogenomes.Tan, Mun Hua; Gan, Hui K ; Schultz, Mark B; Austin, Christopher M
1031-Nov-2014Evaluation of second-line and subsequent targeted therapies in metastatic renal cell cancer (mRCC) patients treated with first-line cediranib.Richter, Suzanne; Seah, Jo-An; Pond, Gregory R; Gan, Hui K ; Mackenzie, Mary J; Hotte, Sebastien J; Mukherjee, Som D; Murray, Nevin; Kollmannsberger, Christian; Heng, Daniel; Haider, Masoom A; Halford, Robert; Ivy, S Percy; Moore, Malcolm J; Sridhar, Srikala S
10429-Oct-2014Poor patient-reported outcomes reporting according to CONSORT guidelines in randomized clinical trials evaluating systemic cancer therapy.Bylicki, O; Gan, Hui K ; Joly, F; Maillet, D; You, B; Péron, J
10530-May-2014Quantitative intratumoural microdistribution and kinetics of (131)I-huA33 antibody in patients with colorectal carcinoma.Ciprotti, Marika; Chong, Geoffrey ; Gan, Hui K ; Chan, Anthony; Murone, Carmel ; MacGregor, Duncan; Lee, Fook-Thean; Johns, Terrance G; Heath, Joan K; Ernst, Matthias ; Burgess, Antony W; Scott, Andrew M 
10630-Apr-2014Prostate Cancer - Double vision but solitary lesionLim, Hui Yin; Perchyonok, Yuliya ; Fitt, Gregory J ; Lokan, Julie ; Wada, Morikatsu ; Fabinyi, Gavin C ; Azad, A; Cher, Lawrence M ; Gan, Hui K 
1076-Feb-2014Mistaken identity: granular cell astrocytoma masquerading as histiocytosis of the central nervous system.Campbell, Robert N; Liew, Mun Sem; Gan, Hui K ; Cher, Lawrence M 
10823-Sep-2013Adherence to CONSORT adverse event reporting guidelines in randomized clinical trials evaluating systemic cancer therapy: a systematic review.Péron, Julien; Maillet, Denis; Gan, Hui K ; Chen, Eric X; You, Benoit
10915-Jan-2013Hypoxia-targeted radiotherapy dose painting for head and neck cancer using (18)F-FMISO PET: a biological modeling study.Chang, Joe H; Wada, Morikatsu ; Anderson, Nigel J; Lim Joon, Daryl ; Lee, Sze Ting ; Gong, Sylvia J; Gunawardana, Dishan H; Sachinidis, John; O'Keefe, Graeme J; Gan, Hui K ; Khoo, Vincent; Scott, Andrew M 
11017-Sep-2012A single centre study of the treatment of relapsed primary central nervous system lymphoma (PCNSL) with single agent temozolomide.Wong, S F; Gan, Hui K ; Cher, Lawrence M 
1111-Jun-2012Targeting of a conformationally exposed, tumor-specific epitope of EGFR as a strategy for cancer therapy.Gan, Hui K ; Burgess, Antony W; Clayton, Andrew H A; Scott, Andrew M 
1126-Apr-2012Assumptions of expected benefits in randomized phase III trials evaluating systemic treatments for cancer.Gan, Hui K ; You, Benoit; Pond, Gregory R; Chen, Eric X
1135-Apr-2011Antibodies in oncology.Pillay, Vinochani; Gan, Hui K ; Scott, Andrew M 
1148-Feb-2010A phase II trial of primary temozolomide in patients with grade III oligodendroglial brain tumors.Gan, Hui K ; Rosenthal, Mark A; Dowling, Anthony; Kalnins, Renate M; Algar, Elizabeth; Wong, Nicholas; Benson, Angela; Woods, Anne-Marie; Cher, Lawrence M 
11524-Dec-2009Neurolymphomatosis: diagnosis, management, and outcomes in patients treated with rituximab.Gan, Hui K ; Azad, Arun A; Cher, Lawrence M ; Mitchell, Paul L R 
11611-May-2009Targeting a unique EGFR epitope with monoclonal antibody 806 activates NF-kappaB and initiates tumour vascular normalization.Gan, Hui K ; Lappas, Martha; Cao, Diana; Cvrljevdic, Anna; Scott, Andrew M ; Johns, Terrance G
1178-Nov-2006The epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor AG1478 increases the formation of inactive untethered EGFR dimers. Implications for combination therapy with monoclonal antibody 806.Gan, Hui K ; Walker, Francesca; Burgess, Antony W; Rigopoulos, Angela; Scott, Andrew M ; Johns, Terrance G
1181-Feb-2006Mannan-MUC1-pulsed dendritic cell immunotherapy: a phase I trial in patients with adenocarcinoma.Loveland, Bruce E; Zhao, Anne; White, Shane C; Gan, Hui K ; Hamilton, Kate ; Xing, Pei-Xiang; Pietersz, Geoffrey A; Apostolopoulos, Vasso; Vaughan, Hilary A; Karanikas, Vaios; Kyriakou, Peter; McKenzie, Ian F C; Mitchell, Paul L R 
11919-Nov-2005A phase 1 and pharmacokinetic study of gemcitabine and oxaliplatin in patients with solid tumors.Gan, Hui K ; Mitchell, Paul L R ; Galettis, Peter; Davis, Ian D; Cebon, Jonathan S ; de Souza, Paul; Links, Matthew
1201-Sep-2005Treatment of human tumor xenografts with monoclonal antibody 806 in combination with a prototypical epidermal growth factor receptor-specific antibody generates enhanced antitumor activity.Perera, Rushika M; Narita, Yoshitaka; Furnari, Frank B; Gan, Hui K ; Murone, Carmel ; Ahlkvist, Marika; Luwor, Rodney B; Burgess, Antony W; Stockert, Elisabeth; Jungbluth, Achim A; Old, Lloyd J; Cavenee, Webster K; Scott, Andrew M ; Johns, Terrance G